Skip to content

Andrey Viktorovich Antsyborov

4 papers in the library · 3 citations · publishing 2017-2020

Papers

Sort Most recent Most cited

Nightmares in Medical Practice

Interactive science March 20, 2020 Anna Valerievna Kalinchuk, Andrey Viktorovich Antsyborov

Nightmares are scary or disturbing dreams which are associated with negative feelings, such as fear, terror or disgust. These feelings oftentimes awake the dreamer, who can easily recollect the content of the nightmare. Nightmares are not necessarily a symptom of a disease. Moreover, nightmares with little emotional response are experienced by almost all people once in a while without any risk...

New psychoactive substances: psychiatrist's view

Interactive science June 21, 2019 Andrey Viktorovich Antsyborov, Irina Vladimirovna Dubatova 1 citation

Appearing not long ago, new psychoactive substances (designer drugs), including synthetic cannabinoids, derivatives of cathinone, phenethylamines, new stimulants, synthetic opioids, tryptamine derivatives, phencyclidine, piperazine, the GABA (A/B) receptors agonists, have become a serious problem for consumers and for physicians. Consumers of these substances are attracted primarily by the...

DOI: 10.21661/r-497066 (opens in new tab) Full text (opens in new tab) MDMA Synthetic cannabinoids Designer drug Cathinone +9

USE OF PSYCHEDELIC SUBSTANCES FOR THERAPEUTIC PURPOSES: IATROGENIC PROBLEM OR JUSTIFIED NECESSITY? PART 1

Neurology Bulletin June 15, 2018 Azat R. Asadullin, Асадуллин Азат Раилевич, Andrey Viktorovich Antsyborov

Hallucinogenic substances are usually classified into several different classes. Most classifications are based on the pharmacological mechanisms of action of these substances and their chemical structure. Psychedelics, entactogens, dissociative substances and “atypical” hallucinogens belongs to chemically heterogeneous group of substances with a hallucinogenic effect. All of the above classes...

Psychiatric aspects of designer drugs and new psychoactive substances consumption

Interactive science February 22, 2017 Vladimir Valerievich Mrykhin, Andrey Viktorovich Antsyborov 2 citations

According to the authors, appeared not long ago new psychoactive substances (designer drugs), including synthetic cannabinoids, derivatives of cathinone, phenethylamines, new stimulants, synthetic opioids, tryptamine derivatives, phencyclidine, piperazine, agonists of GABA (A/B) receptors have become a serious problem for both consumers and doctors. Consumers of these substances are attracted...

DOI: 10.21661/r-116849 (opens in new tab) Full text (opens in new tab) Designer drug Psychoactive substance Consumption sociology Mephedrone +1